pf-04995274
Small moleculeexperimental
Clinical trial activity
7 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01091272)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Serotonin 4 (5-HT4) receptorAGONIST
HTR4 agonist
Chemistry & pharmacology
Loading structure…
SMILES
OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1- Mol. weight
- 432.52 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2152922 ↗
Also known as
- pf-04995274
- pf-04995274
- pf-04995274
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03515733 | Phase 1 | May 31, 2018 | University of Oxford |
| NCT03516604 | Phase 1 | May 16, 2018 | Medical Research Council, Pfizer, University of Oxford |
| NCT01345864 | Phase 1 | May 1, 2011 | Pfizer |
| NCT01193062 | Phase 1 | Sep 1, 2010 | Pfizer |
| NCT01173757 | Phase 1 | Aug 1, 2010 | Pfizer |
| NCT01169714 | Phase 1 | Aug 1, 2010 | Pfizer |
| NCT01091272 | Phase 1 | Apr 1, 2010 | Pfizer |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 6 | 5 | 1 | 2010 |
| University of Oxford | Academic/Hospital | 2 | 2 | 1 | 2018 |
| Medical Research Council | Government | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1